1. Home
  2. ACRS vs MCFT Comparison

ACRS vs MCFT Comparison

Compare ACRS & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aclaris Therapeutics Inc.

ACRS

Aclaris Therapeutics Inc.

HOLD

Current Price

$3.50

Market Cap

311.0M

Sector

Health Care

ML Signal

HOLD

Logo MasterCraft Boat Holdings Inc.

MCFT

MasterCraft Boat Holdings Inc.

HOLD

Current Price

$20.81

Market Cap

329.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRS
MCFT
Founded
2012
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
311.0M
329.0M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
ACRS
MCFT
Price
$3.50
$20.81
Analyst Decision
Strong Buy
Hold
Analyst Count
4
5
Target Price
$9.75
$22.25
AVG Volume (30 Days)
2.5M
144.0K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
69.01
N/A
EPS
N/A
0.38
Revenue
$1,683,000.00
$284,203,000.00
Revenue This Year
N/A
$9.18
Revenue Next Year
$4.24
$8.23
P/E Ratio
N/A
$56.00
Revenue Growth
N/A
N/A
52 Week Low
$1.05
$14.42
52 Week High
$4.89
$26.49

Technical Indicators

Market Signals
Indicator
ACRS
MCFT
Relative Strength Index (RSI) 50.91 48.10
Support Level $2.67 $18.86
Resistance Level $3.86 $21.20
Average True Range (ATR) 0.26 0.71
MACD -0.01 0.19
Stochastic Oscillator 46.32 62.69

Price Performance

Historical Comparison
ACRS
MCFT

About ACRS Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: